3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
3
Unknown
2
Terminated
1
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Motor Activity
34
Neoplasms
17
Breast Neoplasms
15
Carcinoma, Non-Small-Cell Lung
5
Polycystic Ovary Syndrome
4
Lymphoma
4
Sarcopenia
3
Prostatic Neoplasms
3
Lung Neoplasms
3
Fatigue
3
Colorectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pain
2
Ovarian Neoplasms
2
Obesity
2
Malnutrition
2
Lymphedema
2
Insulin Resistance
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Cardiovascular Diseases
2
Weight Cycling
1
Waldenstrom Macroglobulinemia
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Interventions
Echocardiography
4
Electrocardiography
2
sulforaphane
1
schizandrin
1
sacubitril and valsartan sodium hydrate drug combination
1
pegfilgrastim
1
nicotinamide-beta-riboside
1
fructus schizandrae, radix ginseng, radix ophiopogonis drug combination
1
empagliflozin
1
Watchful Waiting
1
Vincristine
1
Tablets
1
Rituximab
1
Proton Therapy
1
Proteins
1
Prednisolone
1
Observation
1
Medical History Taking
1
Lenalidomide
1
Laser-Doppler Flowmetry
1
Exercise
1
Environmental Biomarkers
1
Echocardiography, Stress
1
Doxorubicin
1
Dexrazoxane
1
Cyclophosphamide
1
Clinical Laboratory Techniques
1
Chemoradiotherapy
1
Carvedilol
1
Blood Pressure Determination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Cardiotoxicity
×
Exercise
×
Clear all
NCT06270667
2024-03-22
LYMfit
Norwegian School of Sport Sciences
Phase NA
Recruiting
280 enrolled